Sonic Healthcare Limited · ASX:SHL

Sonic Healthcare — Shareholder Meeting (November 2005)

42 slides from Sonic Healthcare's shareholder meeting presentation, Nov 24, 2005

  1. Slide 1: Annual General Meeting

    Annual General Meeting 24 November 2005 Dr Colin Goldschmidt CEO and Managing Director

  2. Slide 2: Current Status

    Current Status z FY 2004/5 - Record financial results z FY 2005/6 - Tracking to Sonic’s guidance range after 4 months z Service levels and reputation outstanding z Organic growth fuelled by strong global pathology and radiology demand z Platforms for growth in UK, German, USA markets z Company in st

  3. Slide 3: Financial Year 2005 Highlights

    Financial Year 2005 Highlights Growth 2005 vs 2004 Revenue 33% EBITA 33% NPAT 34% Operating Cashflow 40% Core* EPS 21% EPS 31% Dividend (full-year) 20% *Core = Before amortisation of intangibles

  4. Slide 4: 2005 Guidance Delivered

    2005 Guidance Delivered Sonic Guidance Actuals $M $M Revenue 1,330 - 1,370 1,382 EBITA 245 - 260 261 Sonic issued a profit upgrade in February 2005

  5. Slide 5: Revenue Growth

    Revenue Growth 2005 2004 Growth ($M) ($M) (%) Total Revenue 1,382.4 1,037.4 33.3% z Acquisitions completed in FY 2005 – IPN, Endeavour Healthcare/Accord Pathology z Organic growth (non-acquisition) in 2005 ~7% z CPL acquisition (30 September 2005) in USA will boost 2006 revenue growth z Strong organ

  6. Slide 6: Annual Revenue

    Sonic Healthcare Annual Revenue 1,800 1,600 1,400 1,200 1,000 $M 800 600 400 200 0 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006(F) Revenue ($M) 33 41 47 58 89 133 147 174 387 628 860 975 1,037 1,382 1,635 = Forecast 2006 Revenue

  7. Slide 7: Sonic Healthcare Revenue Split

    Sonic Healthcare Revenue Split IPN 5% Radiology 20% Pathology 75%

  8. Slide 8: 2006 Guidance

    2006 Guidance 2005 Actuals 2006 Guidance Growth $M $M % Revenue 1,382 1,600 – 1,670 18.3% EBITA 261 300 – 320 18.8% ƒ Sonic tracking to 2006 guidance range after 4 months ƒ Growth calculated using mid-point of 2006 guidance ƒ Includes full year of IPN ƒ Includes CPL acquisition from 1 October 2005 ƒ

  9. Slide 9: Dividends

    Dividends 2005 2004 Change Interim Dividend $0.13 $0.10 30% Final Dividend $0.23 $0.20 15% Full Year Dividend $0.36 $0.30 20% z Dividend fully franked at 30% z Dividend Reinvestment Plan currently suspended

  10. Slide 10: Full-year dividend history

    Full-year dividend 11 Year History 40 35 30 25 Cents per 20 Share 15 10 5 0 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 Dividend (cents) 3 4 5 9 14 15 17 20 25 30 36

  11. Slide 11: Core Earnings per Share

    Core Earnings per Share 55 52.6 50 45 43.4 40 37.8 35 33.3 Cents 30 27.5 per share 25 21.7 20 16.7 15 11.8 10 9.5 7.0 8.0 6.7 5 2.1 0 0 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 Core Earnings = Before amortisation of intangibles

  12. Slide 12: 10 Years Double-digit EPS Growth

    10 Years Double-digit EPS Growth! SHL - Core Earning per Share Growth (%) 50% 42% 40% 30% 30% 27% 24% 21% 21% 19% 20% 14% 14% 15% 10% 0% 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 Core EPS = Earnings per Share before Amortisation of Intangibles

  13. Slide 13: Share Price (Jan 1990 - Nov 2005)

    $0.00 $2.00 $4.00 $6.00 $8.00 $10.00 $12.00 $14.00 $16.00 31/01/90 31/07/90 31/01/91 31/07/91 31/01/92 31/07/92 31/01/93 31/07/93 31/01/94 31/07/94 31/01/95 31/07/95 31/01/96 31/07/96 31/01/97 31/07/97 31/01/98 31/07/98 31/01/99 31/07/99 31/01/00 Sonic Healthcare 31/07/00 31/01/01 31/07/01 31/01/02

  14. Slide 14: Equity Raising / Share Purchase Plan

    Equity Raising / Share Purchase Plan z Successful capital raising of $225 million in October 2005 z Proceeds used to retire debt associated with CPL acquisition z Priced at $14.54, a 3.5% discount to prior day’s closing price z Share Purchase Plan z Opportunity for loyal shareholders to participate

  15. Slide 15: Sonic Healthcare – International Expansion

    Sonic Healthcare – International Expansion Germany 2004 United Kingdom 2002 United States 2005 Hong Kong 2001 New Zealand 1999 Australia 1987 Sonic Core EPS performance 1997 1998 1999 2000 2001 2002 2003 2004 2005 4

  16. Slide 16: Sonic Healthcare

    SONIC HEALTHCARE

  17. Slide 17: Sonic UK Pathology - History

    Sonic UK Pathology - History z Sonic acquires TDL in 2002 z Sonic acquires Omnilabs in 2003 z Omnilabs merges into TDL in 2004 z TDL relocates to new laboratory facility in 2004 z Sonic/TDL secures major public-private partnership with UCLH in 2004 z UK Government decision to outsource pathology and

  18. Slide 18: UK Pathology - TDL

    UK Pathology - TDL z NHS outsourcing update z Pathology outsourcing tenders delayed due to election and focus on radiology tenders and primary care outsourcing z Pathology tenders expected in first half 2006 z TDL performing well in Harley Street market z TDL – UCLH joint venture progressing well z

  19. Slide 19: German Schottdorf Group

    German Schottcor? Group SONIC HEALTHCARE

  20. Slide 20: German Pathology - Schottdorf

    German Pathology - Schottdorf z Sonic acquired 56% interest in Schottdorf Group in 2004 z Schottdorf business achieved outstanding results in FY 2005 z Strong volume growth and efficiencies z Acquisition earnout of €8.1 million paid in full z Acquisition opportunities in private pathology sector z E

  21. Slide 21: Sonic – Germany Synergies

    Sonic – Germany Synergies z UK – Germany synergies already established z Esoteric pathology specimens transported from TDL to Schottdorf daily z Additional revenue to Schottdorf z Lower testing costs for TDL z Better service delivery and turnaround times z Acquisition opportunities in Germany z Cons

  22. Slide 22: Sonic’s Experience in Germany

    Sonic’s Experience in Germany z Excellent impression of German business market z Similar business culture and standards z Strong legal and accounting systems z No major legislative, tax or legal hurdles z Language z Not an issue z Everyone speaks excellent English! z Financing the transaction z Some

  23. Slide 23: U.S.A Pathology

    U.S.A Pathology CPL SONIC HEALTHCARE

  24. Slide 24: Clinical Pathology Laboratories (CPL)

    Clinical Pathology Laboratories (CPL) z Sonic acquired 82% of CPL on 30 September 2005 for ~US$312 million z CPL is the largest regional independent laboratory in the USA z CPL’s core market is Texas, with newly established markets in Ohio and Virginia (Washington DC area) z Annual revenue of ~US$19

  25. Slide 25: CPL History

    CPL History z 1948 – 1989 Forerunner of CPL, Austin pathologist group z 1990 – 1997 Expansion into San Antonio, Dallas z 1999 Acquisitions of Seguin Labs and Waco Medical Group Lab z 2000 Acquisitions of labs in Houston, Dallas, Denton, Victoria z 2001 CPL recapitalises with entry of private equity

  26. Slide 26: CPL Geographic Markets

    CPL Geographic Markets CPL South West • CPL’s core market • Texas, Oklahoma, Arkansas, Louisiana • South West laboratory market estimated at US$1.3 billion annually • CPL has around 15% share of Texas market (population 22 million) • Major referrals from Austin, Dallas and San Antonio • Extensive ne

  27. Slide 27: CPL Management

    CPL Management z CPL has an experienced and dedicated management team, committed to growing the business with Sonic z Dr Robert Connor, M.D., Chairman, CEO, Medical Director z Qualified and practising pathologist z Became Chairman and CEO of CPL in 1990 z Has driven the medical leadership model of C

  28. Slide 28: Ownership Structure

    Ownership Structure z Initial equity structure: Sonic 82%, CPL management 18% z Non-Sonic shareholders z Largest shareholders: Dr Robert Connor (CEO) and Mr David Schultz (COO) z Other minority shareholders include Pathologists and senior managers z Sonic will move progressively to acquire 100% of C

  29. Slide 29: Corporate Values and Operating Models

    Corporate Values and Operating Models Sonic Sonic Healthcare Healthcare CPL CPL z Medical practice / Medical z Pathologist interaction with leadership clinicians z Respect & honesty z Uncompromising integrity z Responsibility & accountability z Accountability z Personalised service for Doctors z Foc

  30. Slide 30: The United States Pathology Market

    The United States Pathology Market z The US is the largest pathology market in the world z US$40 billion revenue in 2003 z Laboratory testing is linked to the entire US healthcare system z Hospital care, GP and specialist services, nursing homes, home healthcare etc z Pathology expenditure in the US

  31. Slide 31: US Laboratory Market Segments

    US Laboratory Market Segments Laboratory Laboratory Industry Industry Share Share by by Test Test Revenue, Revenue, 2003 2003 Other labs Physician 7% owned labs 7% Hospital Labs………………...~8,500 Independent Labs……….......~5,000 Physician Office Labs….…~110,000 Other Labs…………………..~58,000 Hospital Indep

  32. Slide 32: Independent Laboratory Sector: Revenue Trend

    Independent Laboratory Sector: Revenue Trend 15 13.0 12.4 11.7 12 10.6 9.5 US$ B 9 6 3 1999 2000 2001 2002 2003 The independent laboratory sector grew at an average of 6.9% per annum (1999 – 2003) Source: Washington G2 Reports

  33. Slide 33: The Sonic Healthcare Federation

    The Sonic Healthcare Federation ƒ Local identity preserved ƒ Management autonomy ƒ Central synergy resource • Group purchasing • Benchmarking • IT synergies • E-Health • Shared marketing • Quality Control • Management Training • Inter-referrals • Lab design / Workflow • Work exchange • Financial str

  34. Slide 34: Global Federation Model

    Global Federation Model Australia / New Zealand Sonic Head Office North America Europe / UK

  35. Slide 35: Sonic Board of Directors

    Sonic Board of Directors z Mr Barry Patterson (Chairman) z Dr Colin Goldschmidt (Managing Director) z Mr Chris Wilks (Finance Director) z Mr Peter Campbell z Mr Colin Jackson z Dr Philip Dubois z Dr Hugh Scotton z Mr Lou Panaccio z Company Secretary – Mr Paul Alexander

  36. Slide 36: Sonic Board of Directors

    Sonic Board of Directors z Non-executive Directors z Mr Barry Patterson – Chairman z Mr Peter Campbell z Mr Lou Panaccio z Executive Directors z Dr Colin Goldschmidt – Managing Director z Mr Chris Wilks – Finance Director z Mr Colin Jackson – Commercial Director, Chairman IPN z Dr Philip Dubois – Ch

  37. Slide 37: IPN

    IPN z Sonic holds 72% interest in IPN z IPN results consolidated into Sonic from 26.8.04 z IPN acquisition of Endeavour Healthcare z Completed on 26.11.04 z 18 Medical Centres acquired (Sydney and Perth) z Integration into IPN structure successful z Loan of $8 million from Sonic to fund the acquisit

  38. Slide 38: New Sonic “Super Lab” – Sydney

    New Sonic “Super Lab” – Sydney DHM Central Lab / Sonic Head Office z Rationale z DHM and Sonic moved into current building in 1994 z DHM’s revenue has increased 5-fold since 1994 z Sonic’s revenue has increased from ~$50 million to ~$1,600 million since 1994 z Space issues for both DHM and Sonic Hea

  39. Slide 39: Sonic Core Values

    Sonic Core Values How we should behave z Commit to service excellence z Treat each other with respect and honesty z Demonstrate responsibility and accountability z Strive for continuous improvement z Maintain confidentiality

  40. Slide 40: Sonic Foundation Principles

    Sonic Foundation Principles What our customers want Medical Practice Medical Leadership Technical and Professional Personalised Satisfying Operational and Academic Service for Patient Needs Excellence Expertise Doctors

  41. Slide 41: Future

    Future z Sonic Australian businesses in strong position z Excellent pathology and radiology businesses z Extensive infrastructure z Outstanding relationships with medical profession z Strong offshore growth prospects z CPL opens a major new growth market in the USA z TDL/Sonic UK set for extended gr

  42. Slide 42: Thank you

    Thank you SONIC HEALTHCARE

Sonic Healthcare — Shareholder Meeting (November 2005) on 6ix